During the past decade, Claude Mandel Medical Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Claude Mandel Medical Center" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Arena Pharmaceuticals" with 1 trials sponsored, "Neurogastrx, Inc." with 1 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored and "Sucampo Pharma Americas, LLC" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Claude Mandel Medical Center" #1 collaborator was "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Claude Mandel Medical Center" are "Crohn's Disease" (2 trials), "Arthritis, Rheumatoid" (1 trials), "Crohn Disease" (1 trials), "Diabetic Gastroparesis" (1 trials) and "Idiopathic Gastroparesis" (1 trials). Many other conditions were trialed in "Claude Mandel Medical Center" in a lesser frequency.

Most popular intervention types in "Claude Mandel Medical Center" are "Drug" (7 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Guselkumab" (2 trials), "Guselkumab Dose 1" (2 trials), "Guselkumab Dose 2" (2 trials) and "Guselkumab Dose 3" (2 trials). Other intervention names were less common.

The vast majority of trials in "Claude Mandel Medical Center" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Claude Mandel Medical Center". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Claude Mandel Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Claude Mandel Medical Center, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".